158 related articles for article (PubMed ID: 19336558)
1. Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Schenk JM; Riboli E; Chatterjee N; Leitzmann MF; Ahn J; Albanes D; Reding DJ; Wang Y; Friesen MD; Hayes RB; Peters U
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1227-31. PubMed ID: 19336558
[TBL] [Abstract][Full Text] [Related]
2. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.
Nash SH; Till C; Song X; Lucia MS; Parnes HL; Thompson IM; Lippman SM; Platz EA; Schenk J
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1507-15. PubMed ID: 26269564
[TBL] [Abstract][Full Text] [Related]
3. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
4. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
Key TJ; Appleby PN; Travis RC; Albanes D; Alberg AJ; Barricarte A; Black A; Boeing H; Bueno-de-Mesquita HB; Chan JM; Chen C; Cook MB; Donovan JL; Galan P; Gilbert R; Giles GG; Giovannucci E; Goodman GE; Goodman PJ; Gunter MJ; Hamdy FC; Heliövaara M; Helzlsouer KJ; Henderson BE; Hercberg S; Hoffman-Bolton J; Hoover RN; Johansson M; Khaw KT; King IB; Knekt P; Kolonel LN; Le Marchand L; Männistö S; Martin RM; Meyer HE; Mondul AM; Moy KA; Neal DE; Neuhouser ML; Palli D; Platz EA; Pouchieu C; Rissanen H; Schenk JM; Severi G; Stampfer MJ; Tjønneland A; Touvier M; Trichopoulou A; Weinstein SJ; Ziegler RG; Zhou CK; Allen NE;
Am J Clin Nutr; 2015 Nov; 102(5):1142-57. PubMed ID: 26447150
[TBL] [Abstract][Full Text] [Related]
5. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Cancer Causes Control; 2012 Nov; 23(11):1865-73. PubMed ID: 22926301
[TBL] [Abstract][Full Text] [Related]
6. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
Goodman GE; Schaffer S; Omenn GS; Chen C; King I
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
[TBL] [Abstract][Full Text] [Related]
7. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
Weinstein SJ; Peters U; Ahn J; Friesen MD; Riboli E; Hayes RB; Albanes D
PLoS One; 2012; 7(7):e40204. PubMed ID: 22792240
[TBL] [Abstract][Full Text] [Related]
8. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
[TBL] [Abstract][Full Text] [Related]
9. Serum retinol and risk of prostate cancer.
Mondul AM; Watters JL; Männistö S; Weinstein SJ; Snyder K; Virtamo J; Albanes D
Am J Epidemiol; 2011 Apr; 173(7):813-21. PubMed ID: 21389041
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
[TBL] [Abstract][Full Text] [Related]
11. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.
Key TJ; Appleby PN; Allen NE; Travis RC; Roddam AW; Jenab M; Egevad L; Tjønneland A; Johnsen NF; Overvad K; Linseisen J; Rohrmann S; Boeing H; Pischon T; Psaltopoulou T; Trichopoulou A; Trichopoulos D; Palli D; Vineis P; Tumino R; Berrino F; Kiemeney L; Bueno-de-Mesquita HB; Quirós JR; González CA; Martinez C; Larrañaga N; Chirlaque MD; Ardanaz E; Stattin P; Hallmans G; Khaw KT; Bingham S; Slimani N; Ferrari P; Rinaldi S; Riboli E
Am J Clin Nutr; 2007 Sep; 86(3):672-81. PubMed ID: 17823432
[TBL] [Abstract][Full Text] [Related]
12. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Travis RC; Crowe FL; Allen NE; Appleby PN; Roddam AW; Tjønneland A; Olsen A; Linseisen J; Kaaks R; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Vineis P; Palli D; Tumino R; Sieri S; Bueno-de-Mesquita HB; van Duijnhoven FJ; Chirlaque MD; Barricarte A; Larrañaga N; González CA; Argüelles MV; Sánchez MJ; Stattin P; Hallmans G; Khaw KT; Bingham S; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
Am J Epidemiol; 2009 May; 169(10):1223-32. PubMed ID: 19359375
[TBL] [Abstract][Full Text] [Related]
13. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
[TBL] [Abstract][Full Text] [Related]
15. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
16. Serum selenium and risk of prostate cancer-a nested case-control study.
Peters U; Foster CB; Chatterjee N; Schatzkin A; Reding D; Andriole GL; Crawford ED; Sturup S; Chanock SJ; Hayes RB
Am J Clin Nutr; 2007 Jan; 85(1):209-17. PubMed ID: 17209198
[TBL] [Abstract][Full Text] [Related]
17. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
18. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
19. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort.
Gill JK; Franke AA; Steven Morris J; Cooney RV; Wilkens LR; Le Marchand L; Goodman MT; Henderson BE; Kolonel LN
Cancer Causes Control; 2009 Sep; 20(7):1161-71. PubMed ID: 19212706
[TBL] [Abstract][Full Text] [Related]
20. Serum creatinine and prostate cancer risk in a prospective study.
Weinstein SJ; Mackrain K; Stolzenberg-Solomon RZ; Selhub J; Virtamo J; Albanes D
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2643-9. PubMed ID: 19755655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
